DailyIQ
Last updated 2 minutes ago

KVUE·Kenvue Inc.

$.
-. (-.%)
After Hours
High
$17.69
Open
$17.62
Market Cap
33.87B
52W High
$23.94
Low
$17.24
P. Close
$17.28
P/E
20.88
52W Low
$14.02
Fwd P/E
13.97
Mean Target
$19.50
Technical Score (1D)
27
SELL
News Sentiment
70
BULLISH
Kenvue (KVUE) has been recognized by Zacks Rank as a Strong Buy income stock, highlighting positive analyst sentiment regarding its income-generating potential. This designation, along with a 4.7% dividend yield that significantly outperforms the industry average, positions KVUE favorably for income-focused investors. The company's current year earnings estimates have also seen a positive upward revision of 5.5% over the past 60 days, suggesting a robust outlook. In parallel, Kenvue is partnering with Greyparrot, an AI waste intelligence firm, to enhance the recyclability of its global packaging. This initiative aims to replace theoretical assumptions with real-world recycling performance data, driven by increasing regulatory pressures like the EU's PPWR and EPR. The focus on data-driven insights to meet evolving regulatory requirements signals a strategic commitment to sustainability and potentially impacts operational costs associated with waste management. Traders should monitor how these sustainability efforts and regulatory compliance translate into operational efficiencies and cost savings. Separately, Kenvue and L'Oreal SA (LRLCY) are being presented as value stock candidates, with Kenvue holding a Zacks Rank of #2 (Buy) compared to L'Oreal's #3 (Hold). The analysis centers on traditional valuation metrics to identify undervalued stocks within the Consumer Products - Staples sector, suggesting investors should monitor these underlying metrics for comparative insights. Despite recent share price weakness, Kenvue's stock performance is being evaluated against its intrinsic worth, with recent modest short-term gains contrasting with significant long-term declines, indicating a shift in market sentiment and perceived risk. Investors will also note that an insider recently sold shares worth over $679,000, a transaction that provides a data point on internal confidence levels.
Earnings Summary
Kenvue Inc. is a global consumer health company with a diverse portfolio of well-known brands across its Self Care, Skin Health and Beauty, and Essential Health segments. Operating internationally, Kenvue offers a broad range of consumer health solutions, positioning it within the Consumer Defensive sector's Household & Personal Products industry. The company's recent performance shows a pattern of exceeding analyst expectations for earnings per share. In Q1 2026, Kenvue reported actual EPS of $0.32, surpassing the estimate of $0.30627, and revenue of $3.909 billion, slightly below the estimate of $3.919 billion. This follows a strong Q4 2025 where actual EPS of $0.27 beat the estimate of $0.2256, with actual revenue of $3.780 billion exceeding the estimate of $3.754 billion. Prior to this, Kenvue demonstrated consistent EPS beats in Q3 2025 ($0.28 actual vs $0.26485 estimate), Q2 2025 ($0.29 actual vs $0.2837 estimate), and Q1 2025 ($0.24 actual vs $0.22766 estimate), indicating a positive trend in meeting or surpassing earnings targets. Revenue figures for earlier quarters were not provided with estimates, making a direct comparison difficult. Recent news highlights Kenvue's Q1 2026 results, which included a 4.5% increase in net sales and a 33% rise in adjusted diluted EPS to $0.32, alongside a 47% jump in diluted EPS to $0.25. This strong operational performance, particularly in skin health and beauty, occurred amidst speculation about a potential acquisition by Kimberly-Clark. Investors will be watching for Kenvue's ability to sustain this sales and profitability momentum in the upcoming quarters, especially considering the ongoing macroeconomic variability and the potential impact of the anticipated acquisition closing in the latter half of 2026.

EPS

EstBeatMiss
$0.21$0.24$0.27$0.30$0.33Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.32 - -
Q1'26$0.31$0.32+4.5%
Q4'25$0.23$0.27+19.7%
Q3'25$0.26$0.28+5.7%
Q2'25$0.28$0.29+2.2%
Q1'25$0.23$0.24+5.4%

Revenue

EstBeatMiss
$3.7B$3.8B$3.9B$3.9B$4.0BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$4.0B - -
Q1'26$3.9B$3.9B-0.3%
Q4'25$3.8B$3.8B+0.7%
Q3'25 - $3.8B -
Q2'25 - $3.8B -
Q1'25 - $3.7B -

Market Data

KVUE Stock Snapshot

KVUE is currently trading at $17.35, giving Kenvue Inc. a market cap of 33.87B and a P/E ratio of 20.9. Today's range spans $17.24–$17.69, with shares opening at $17.62 and moving up $0.07 (0.4%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 70/100.

Over the past year KVUE has traded between $14.02 and $23.94 - the current price is +23.8% off the 52-week low and -27.5% from the high. 21 analysts cover the stock with a Hold consensus and a mean 12-month target of $19.50 (range $18.00–$23.00), implying upside of +12.4%.

Sector rotation is working against KVUE - large-cap, Consumer Defensive, 33.87B market cap. Technical score 27/100 (SELL), sentiment bullish (70/100), price $17.35 (in the lower half of its 52-week range). (P/E: 20.9) When capital rotates out of a sector, large-cap names with bearish technicals are the first to absorb the selling. Annual range $14.02–$23.94 frames where the next potential demand zone resides.

When a large-cap Consumer Defensive name with 33.87B in capitalization prints a SELL signal (27/100) alongside bullish news sentiment (70/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $17.35 (in the lower half of its 52-week range in the $14.02–$23.94 range), the structural support levels are where that sponsorship question gets answered.